409 related articles for article (PubMed ID: 29774446)
1. Contemporary Review of Peyronie's Disease Treatment.
Capoccia E; Levine LA
Curr Urol Rep; 2018 May; 19(7):51. PubMed ID: 29774446
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
3. Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.
Yousif A; Natale C; Hellstrom WJG
Curr Urol Rep; 2021 Jan; 22(2):6. PubMed ID: 33420664
[TBL] [Abstract][Full Text] [Related]
4. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
5. Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.
Wymer K; Kohler T; Trost L
J Sex Med; 2019 Sep; 16(9):1421-1432. PubMed ID: 31351851
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
7. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
10. A state-of-art review on collagenase
Chung E; Scott S; Wang J
Expert Opin Biol Ther; 2020 Jun; 20(6):559-564. PubMed ID: 32345061
[No Abstract] [Full Text] [Related]
11. Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease.
Yafi FA; Diao L; DeLay KJ; DeYoung L; Talib R; Alzweri L; Brock G; Hellstrom WJG; Hatzichristodoulou G
Urology; 2018 Oct; 120():138-142. PubMed ID: 30059716
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
[TBL] [Abstract][Full Text] [Related]
13. Review of Management Options for Active-Phase Peyronie's Disease.
Brimley SC; Yafi FA; Greenberg J; Hellstrom WJG; Tue Nguyen HM; Hatzichristodoulou G
Sex Med Rev; 2019 Apr; 7(2):329-337. PubMed ID: 30503796
[TBL] [Abstract][Full Text] [Related]
14. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
15. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
Dhillon S
Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
[TBL] [Abstract][Full Text] [Related]
16. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Abdel Raheem A; Johnson M; Ralph D; Garaffa G
Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
[TBL] [Abstract][Full Text] [Related]
17. Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
Gelbard MK; Chagan L; Tursi JP
J Sex Med; 2015 Jun; 12(6):1481-9. PubMed ID: 25940867
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
19. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review and Single-Center Cohort Analysis.
Amighi A; Eleswarapu SV; Mendhiratta N; Nork JJ; Mills JN
Sex Med Rev; 2019 Oct; 7(4):690-698. PubMed ID: 31196763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
